Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | AR | P10275 | 2/20 | 0.50 |
| ▸ | FDPS | P14324 | 6/20 | 0.49 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.49 |
| ▸ | KARS1 | Q15046 | 3/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | RXRB | P28702 | 1/20 | 0.40 |
| ▸ | RXRG | P48443 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | BCL9 | O00512 | 3/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3706021 | 0.82 | CYP3A4 (0.69) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL3212768 | 0.75 | CYP3A4 (0.78) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL20364223 | 0.75 | CYP3A4 (0.78) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL14201538 | 0.74 | CYP3A4 (0.74) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL31291111 | 0.73 | AR (0.68) | CYP3A4ALDH1A1MAPTALOX15AR | |
| 7-Oxocallitrisic Acid, Methyl Ester SCHEMBL15339316 | 0.73 | CYP3A4 (1.00) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL26222356 | 0.72 | AR (0.78) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL14207873 | 0.72 | CYP3A4 (0.74) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL15388987 | 0.71 | CYP3A4 (0.64) | CYP3A4ALDH1A1MAPTALOX15AR | |
| SCHEMBL15388986 | 0.71 | CYP3A4 (0.64) | CYP3A4ALDH1A1MAPTALOX15AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4401711-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401714-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401712-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-4401713-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| US-20240165036-A1 | ENCAPSULATED VITAMIN D | Nulixir Inc. | 2024-05-23 | — | — | US | disclosed |
| US-20230404126-A1 | ENCAPSULATED PRECURSORS OF NICOTINAMIDE ADENINE DINUCLEOTIDE AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-12-21 | — | — | US | disclosed |
| US-20230157963-A1 | SOLID ORAL BEADS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-05-25 | — | — | US | disclosed |
| US-20230157973-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-05-25 | — | — | US | disclosed |
| US-20230149829-A1 | ORAL COMPOSITIONS OF PLANTS THROUGH A DOUBLE EXTRACTION SYSTEM AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-05-18 | — | — | US | disclosed |
| US-20230111238-A1 | STABLE COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-04-13 | — | — | US | disclosed |
| US-20230111190-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-04-13 | — | — | US | disclosed |
| US-20230111756-A1 | STABLE FORMULATIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-04-13 | — | — | US | disclosed |
| US-20230110485-A1 | MULTI-LAYER PARTICLES OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-04-13 | — | — | US | disclosed |
| WO-2023043855-A1 | ORAL COMPOSITIONS WITH PLANT MATTER EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023043853-A1 | ORAL COMPOSITIONS WITH IMPROVED BIOAVAILABILITY AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023043852-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023043854-A1 | ALIMENTARY-RELATED PARTICLES, PRODUCTION METHODS, AND PRODUCTION APPARATUS | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | disclosed |
| US-20230081296-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |
| US-20230082651-A1 | STABLE AQUEOUS COMPOSITIONS OF PLANTS EXTRACTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |
| US-20230079480-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | disclosed |